Hyperspectral molecular imaging of multiple receptors using immunolabeled plasmonic nanoparticles

Journal of Biomedical Optics

Volumn 16, Issue 11, 2011, Pages

  Seekell, Kevin ^a   Crow, Matthew J ^a   Marinakos, Stella ^b   Ostrander, Julie ^c   Chilkoti, Ashutosh ^a   Wax, Adam ^a  

^a Duke University   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cancer cells; immunophenotype; molecular imaging; multiplexing; nanoparticles; plasmonics

Indexed keywords

CANCER CELLS; CELL LINES; CELL RECEPTORS; COUPLING MECHANISM; DARKFIELD MICRO-SPECTROSCOPY; GOLD NANOROD; GOLD NANOSPHERES; GROWTH FACTOR; HUMAN EPIDERMAL GROWTH FACTOR; HYPERSPECTRAL; IMMUNOPHENOTYPES; MOLECULAR IMAGING; MOLECULAR MARKER; MOLECULAR TAGS; MULTIPLE RECEPTORS; PLASMON COUPLING; PLASMONIC NANOPARTICLE; PLASMONICS; RECEPTOR SIGNALING; RESONANCE PEAK; SCATTERING PROFILES; SCATTERING SPECTRA; SIMULTANEOUS IMAGING; SINGLE OPTICAL SOURCE;

CELL CULTURE; CELL MEMBRANES; DISEASES; NANOPARTICLES; NANORODS; NANOSPHERES; PEPTIDES;

PLASMONS;

CELL SURFACE RECEPTOR; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; NANOPARTICLE; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL LINE; CHEMISTRY; HUMAN; IMMUNOPHENOTYPING; METHODOLOGY; MOLECULAR IMAGING; RADIATION SCATTERING;

CELL LINE; HUMANS; IMMUNOPHENOTYPING; MOLECULAR IMAGING; NANOPARTICLES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, IGF TYPE 1; RECEPTORS, CELL SURFACE; SCATTERING, RADIATION;

EID: 80655143472     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3646529     Document Type: Article

References (36)

1. H. Wang and T. Vo-Dinh, Multiplex detection of breast cancer biomarkers using plasmonic molecular sentinel nanoprobes., Nanotechnology 20 (6), 065101 (2009). 10.1088/0957-4484/20/6/065101
2. A. M. Derfus, W. Chan, and S. N. Bhatia, Probing the cytotoxicity of semiconductor quantum dots., Nano Lett. 4 (1), 11-18 (2004). 10.1021/nl0347334 (Pubitemid 38167855)
3. B. Dubertret, P. Skourides, D. J. Norris, V. Noireaux, A. H. Brivanlou, and A. Libchaber, In vivo imaging of quantum dots encapsulated in phospholipid micelles.. Science 298 (5599), 1759-1762 (2002). 10.1126/science.1077194 (Pubitemid 35404113)
4. K. Kelly, E. Coronado, L. Zhao, and G. Schatz, The optical properties of metal NPs: The influence of size, shape, and dielectric environment., J. Phys. Chem. B 107 (3), 668-677 (2003). 10.1021/jp026731y
5. M. Marmor, K. Skaria, and Y. Yarden, Signal transduction and oncogenesis by ErbBHER receptors., Int. J. Radiat. Oncol., Biol., Phys. 58 (3), 903-913 (2004). 10.1016/j.ijrobp.2003.06.002 (Pubitemid 38221150)
6. R. Nicholson, J. Gee, and M. Harper, EGFR and cancer prognosis., Eur. J. Cancer 37 (4), 9-15 (2001). 10.1016/S0959-8049(01)00231-3
7. R. Diaco, Practical Considerations for the Design of Quantitative PCR Assays in PCR Strategies, M. A. Innis, D. H. Gelfand, J. J. Sninsky, Eds., pp. 84-110, Academic Press, San Diego, CA (1995).
8. M. Ellis, F. Garmoudi, and K. Cullen, Insulin Receptors (IGF1 and IGF2)., Encyclopedia of Cancer, Vol. 2, pp. 927-939 (1997).
9. J. Riedemann and V. M. Macaulay, IGF1R signalling and its inhibition., Endocrine-Related Cancer 13 (1), S33-S43 (2006). 10.1677/erc.1.01280 (Pubitemid 46219247)
10. I. Skirnisdttir, B. Sorbe, and T. Seidal, The growth factor receptors HER-2neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma., Int. J. Gynecological Cancer 11 (2), 119-129 (2008). 10.1046/j.1525-1438.2001.00086.x
11. K. Chen, Y. Liu, G. Ameer, and V. Backman, Optimal design of structured nanospheres for ultrasharp light-scattering resonances as molecular imaging multilabels., J. Biomed. Opt. 10 (2), 024005 (2005). 10.1117/1.1899684 (Pubitemid 41046583)
12. B. Nikoobakht and M. El-Sayed, Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method., Chem. Mater. 15 (10), 1957-1962 (2003). 10.1021/cm020732l
13. X. Huang, I. El-Sayed, W. Qian, and M. El-Sayed, Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker., Nano Lett. 7 (6), 1591-1597 (2007). 10.1021/nl070472c (Pubitemid 47140430)
14. A. Curry, G. Nusz, A. Chilkoti, and A. Wax, Analysis of total uncertainty in spectral peak measurements for plasmonic NP-based biosensors., Appl. Opt. 46 (10), 1931-1939 (2007). 10.1364/AO.46.001931 (Pubitemid 46659562)
15. K. Sokolov, M. Follen, J. Aaron, I. Pavlova, A. Malpica, R. Lotan, and R. Richards-Kortum, Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles., Cancer Res. 63 (9), 1999-2004 (2003). (Pubitemid 36538596)
16. J. Aaron, N. Nitin, K. Travis, S. Kumar, T. Collier, S. Y. Park, M. Jose-Yacaman, L. Coghlan, M. Follen, R. Richards-Kortum, and K. Sokolov, Plasmon resonance coupling of metal NPs for molecular imaging of carcinogenesis in vivo., J. Biomed. Opt. 12 (3), 034007 (2007). 10.1117/1.2737351 (Pubitemid 47260254)
17. C. Loo, A. Lowery, N. Halas, J. West, and R. Drezek, Immunotargeted nanoshells for integrated cancer imaging and therapy., Nano Lett. 5 (4), 709-712 (2005). 10.1021/nl050127s (Pubitemid 40609745)
18. J. Filmus, M. N. Pollak, R. Cailleau, and R. N. Buick, MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF., Biochem. Biophys. Res. Commun. 128 (2), 898-905 (1985). 10.1016/0006-291X(85) 90131-7 (Pubitemid 15000428)
19. G. D. Lewis, I. Figari, B. Fendly, W. L. Wong, P. Carter, C. Gorman, and H. M. Shepard, Differential responses of human tumor cell lines to anti-p185 HER2 monoclonal antibodies., Cancer Immunol. Immunother 37 (4), 255-263 (1993). 10.1007/BF01518520 (Pubitemid 23300507)
20. J. Riedemann, M. Takiguchi, M. Sohail, and V. M. Macaulay, The EGF receptor interacts with the type 1 IGF receptor and regulates its stability., Biochem. Biophys. Res. Commun. 355 (3), 707-714 (2007). 10.1016/j.bbrc.2007.02. 012 (Pubitemid 46330209)
21. M. Cuello, S. Ettenberg, A. Clark, M. Keane, R. Posner, M. Nau, P. Dennis, and S. Lipkowitz, Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2., Cancer Res. 61 (12), 4892-4900 (2001). (Pubitemid 32691907)
22. A. Chakraborty, A. Welsh, and M. DiGiovanna, Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines., Breast Cancer Res. Treat. 120 (2), 327-335 (2010). 10.1007/s10549-009-0382-5
23. G. Kramer-Marek, D. O. Kiesewetter, and J. Capala, Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and 18F-labeled affibody molecules., J. Nucl. Med. 50 (7) 1131-1139 (2009). 10.2967/jnumed.108.057695
24. M. J. Crow, Plasmonic flow cytometry by immunolabeled nanorods., Cytometry, Part A 79A (1), 57-65 (2011). 10.1002/cyto.a.20994
25. M. J. Crow and A. Wax, Development of a novel hyperspectral darkfield microscopy system for characterization of NP sensors., Biomedical Optics, OSA Technical Digest, BSuE6 (2008).
26. A. Curry, W. Hwang, and A. Wax, Epi-illumination through the microscope objective applied to darkfield imaging and microspectroscopy of NP interaction with cells in culture., Opt. Express 14 (14), 6535-6542 (2006). 10.1364/OE.14.006535 (Pubitemid 44036386)
27. A. Curry, M. Crow, and A. Wax, Molecular imaging of epidermal growth factor receptor in live cells with refractive index sensitivity using dark-field microspectroscopy and immunotargeted NPs., J. Biomed. Opt. 13 (1), 014022 (2008). 10.1117/1.2837450
28. Y. Gong, E. Yao, R. Shen, A. Goel, M. Arcila, J. Teruya-Feldstein, M. F. Zakowski, S. Frankel, M. Peifer, R. K. Thomas, M. Ladanyi, and W. Pao, High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)., PLoS ONE 4 (10), e7273 (2009). 10.1371/journal.pone.0007273
29. L. Ge, Y. Ly, M. Hollenberg, and K. DeFea, A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis., J. Biol. Chem. 278 (36), 34418-34426 (2003). 10.1074/jbc.M300573200 (Pubitemid 37553288)
30. M. Crow, K. Seekell, J. H. Ostrander, and A. Wax, Monitoring of receptor dimerization using plasmonic coupling of gold NPs.. ACS Nano (2011) (under review).
31. M. Hancock, B. Langton, T. Chan, P. Toy, J. Monahan, R. Mischak, and L. Shawver, A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.. Cancer Res. 51 (17), 4575-4580 (1991).
32. C. Yu, H. Nakshatri, and J. Irudayaraj, Identity profiling of cell surface markers by multiplex gold nanorod probes.. Nano Lett. 7 (8), 2300-2306 (2007). 10.1021/nl070894m (Pubitemid 47310123)
33. M. Crow, G. Grant, J. Provenzale, and A. Wax, Molecular imaging and quantitative measurement of epidermal growth factor receptor expression in live cancer cells using immunolabeled gold NPs., AJR, Am. J. Roentgenol. 192 (4), 1021-1028 (2008). 10.2214/AJR.07.3535
34. M. Crow, K. Seekell, and A. Wax, Polarization mapping of NP plasmonic coupling., Opt. Lett. 36 (5), 757-759 (2011). 10.1364/OL.36.000757
35. W. Shi, Y. Sahoo, M. Swihart, and P. Prasad, Gold nanoshells on polystyrene cores for control of surface plasmon resonance., Langmuir 21 (4), 1610-1617 (2005). 10.1021/la047628y (Pubitemid 40275102)
36. C. Desbois-Mouthon, W. Cacheux, M. J. Blivet-Van Eggelpol, V. Barbu, L. Fartoux, R. Poupon, C. Housset, and O. Rosmorduc, Impact of IGF-1REGFR cross-talks on hepatoma cell sensitivity to gefitinib., Int. J. Cancer 119 (11), 2557-2566 (2006). 10.1002/ijc.22221 (Pubitemid 44691308)